SCHEMBL5309294

SCHEMBL5309294

ClCCN(CCCl)Nc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.36
TDP1 Q9NUW8 6/20 0.36
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 2/20 0.36
CTSD P07339 1/20 0.36
TSHR P16473 3/20 0.35
PTGS2 P35354 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ALOX15 P16050 1/20 0.35
ALOX12 P18054 1/20 0.35
PTGS1 P23219 1/20 0.35
SLC6A2 P23975 1/20 0.35
MAPK1 P28482 1/20 0.35
HTR2B P41595 1/20 0.35
MAPT P10636 1/20 0.34
IDO1 P14902 2/20 0.33
SLC22A2 O15244 1/20 0.33
SLC22A3 O75751 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8507986 0.98 HTT (0.35) HTTTDP1ALDH1A1HSD17B10CTSD
SCHEMBL2896837 0.77 KDM4E (0.40) TDP1ALDH1A1HSD17B10CTSDTSHR
SCHEMBL8360966 0.77 IDO1 (0.39) TDP1ALDH1A1HSD17B10CTSDTSHR
SCHEMBL11418786 0.76 TDP1 (0.44) HTTTDP1ALDH1A1SLC6A2MAPT
Oxalic Acid SCHEMBL8509058 0.74 MEN1 (0.49) HTTTSHRRAB9ASMN1; SMN2KDM4E
SCHEMBL9005274 0.72 KCNH2 (0.51) HTTALDH1A1RAB9AKMT2APAX8
SCHEMBL50189 0.71 L3MBTL1 (0.52) TDP1ALDH1A1HSD17B10CTSDTSHR
SCHEMBL7903849 0.71 SMN1; SMN2 (0.38) ALDH1A1L3MBTL1MAPTRAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL11760188 0.70 L3MBTL1 (0.50) TDP1ALDH1A1HSD17B10CTSDTSHR
SCHEMBL30998804 0.70 ALDH1A1 (0.47) TDP1ALDH1A1CTSDTSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103626776-B Pyrazolo[1,5-alpha] pyrimidine nitrogen mustard derivatives, preparation methods of pyrazolo[1,5-alpha] pyrimidine nitrogen mustard derivatives, and application of pyrazolo[1,5-alpha] pyrimidine nitrogen mustard derivatives in oncotherapy 北京师范大学 2017-02-15 CN disclosed
CN-103626776-A Pyrazolo[1,5-alpha] pyrimidine nitrogen mustard derivatives, preparation methods of pyrazolo[1,5-alpha] pyrimidine nitrogen mustard derivatives, and application of pyrazolo[1,5-alpha] pyrimidine nitrogen mustard derivatives in oncotherapy UNIV BEIJING NORMAL 2014-03-12 CN disclosed
WO-2007040565-A9 ENHANCING TREATMENT OF CANCER AND HIF-1 MEDIATED DISODERS WITH ADENOSINE A3 RECEPTOR ANTAGONISTS KING PHARMACEUTICALS RES & DEV (US) 2007-07-05 WO disclosed